Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly’s...
BLOG
Read on
Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing Capabilities
BLUE ASH, Ohio, June 18, 2026 – Resilience, along with Ohio Governor Mike DeWine, JobsOhio, the City of Blue Ash, and REDI Cincinnati, today...
Alachua Campus Tour Video
With a sustainable network of high-tech, end-to-end manufacturing facilities across North America, Resilience has become a powerhouse in how...
Revised Annex 1 and the Focus on Microbial Control Strategies
The updates to EU Annex 1 added a great deal of emphasis on microbial control. By performing gap assessments and developing thorough, site-specific...
Starburst Data Rebel Awards: Data Product of the Year
We are proud to announce that Adam Mendez, Head of Data Engineering and Architecture and the Data Platform Team at Resilience, has won the Starburst...
Building Velocity into Fill/Finish Timelines: Your Guide to Quality and Regulatory Success in the CDMO Space
Manufacturing capabilities need innovation proportional to those in therapeutics discovery. Choosing a CDMO partner with the technologies and...
On-Demand Webinar: Outsourced Pharma Capacity Update 2024 - Large Molecules
Are you an innovative company looking for a dependable CDMO partner for your large molecule projects? You have come to the right place.
On-demand Webinar: Optimize research and delivery of complex medicines using data insights
Event Overview: The Life Sciences industry relies on vast amounts of data to rapidly evaluate their novel therapies confidently at a global scale. To...
